These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29870138)

  • 1. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
    Xu S; Liu R; Da Y
    Thorac Cancer; 2018 Aug; 9(8):974-988. PubMed ID: 29870138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L; Zhang L
    BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of
    Hou Y; Tan S; Wang G
    Genet Test Mol Biomarkers; 2021 May; 25(5):346-354. PubMed ID: 33956533
    [No Abstract]   [Full Text] [Related]  

  • 7. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma.
    Ma X; Yang S; Jiang H; Wang Y; Xiang Z
    J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
    Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
    Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma.
    Wang Y; Zhang L; Chen Y; Li M; Ha M; Li S
    J Clin Lab Anal; 2020 Oct; 34(10):e23450. PubMed ID: 32672359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
    Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
    Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
    Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
    Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
    Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
    Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RACGAP1 is a pivotal gene in lung adenocarcinoma-associated membranous nephropathy: Based on comprehensive bioinformatics analysis and machine learning.
    Xu Q; Li J; Zhuo L; Gao H; Yang Y; Li W
    Int Immunopharmacol; 2024 Sep; 139():112783. PubMed ID: 39068752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
    Luo B; Gu YY; Wang XD; Chen G; Peng ZG
    Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
    Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
    Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
    Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
    Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.